We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Selcia and Heptares Therapeutics Announce New Fragment Screening Collaboration

News   Apr 19, 2012

 
Selcia and Heptares Therapeutics Announce New Fragment Screening Collaboration
 
 
 

RELATED ARTICLES

Multi-organ "Human-on-a-Chip" Enables Long-term Toxicology Testing

News

The microfluidic device with interlinking modules containing human-derived heart, liver, skeletal muscle and nervous system cells was able to maintain cellular viability and record cellular function in real-time for 28 days.

READ MORE

Study Could Lead to Sun Protection for Patients With Rare Genetic Disease

News

Skin cells taken from patients with a rare genetic disorder are up to ten times more sensitive to damage from ultraviolet A radiation in laboratory tests, than those from a healthy population, according to new research from the University of Bath.

READ MORE

Active Component of "Holy Herb" a Neuroprotective Candidate

News

The discovery of a potent neuroprotective and anti-inflammatory chemical in a native California shrub has been raised as a potential therapeutic candidate.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE